lenalidomide krka d.d.
krka, d.d., novo mesto - lenalidomide hydrochloride hydrate - multiple myeloma; lymphoma, follicular; myelodysplastic syndromes - imunosupresivi - multiple myelomalenalidomide krka d. as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indiciran za zdravljenje odraslih bolnikov s predhodno nezdravljenih več plazmocitom, ki niso primerni za presaditev. lenalidomide krka d. in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka d. as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. follicular lymphomalenalidomide krka d. in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).
abiraterone krka
krka, d.d., novo mesto - abirateron acetat - prostatične neoplazme - endokrini terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
novo helisen depot 006 trave
kemofarmacija d.d. - suspenzija za injiciranje - cvetni prah trav
novo helisen depot 006 trave
kemofarmacija d.d. - suspenzija za injiciranje - cvetni prah trav
novo helisen depot 012 drevesa i 2x4,5 ml
suspenzija - razni alergenski ekstrakti
novo helisen depot 012 drevesa i 4 x4,5 ml
suspenzija - razni alergenski ekstrakti
novo helisen depot 013 drevesa ii 4 x4,5 ml
suspenzija - razni alergenski ekstrakti
novo helisen depot 108+115+129 drevesa, začetno zdravljenje
kemofarmacija d.d. - suspenzija za injiciranje - drevesni cvetni prah
novo helisen depot 725 d.pteronyssinus, začetno zdravljenje
kemofarmacija d.d. - suspenzija za injiciranje - pršice v hišnem prahu
novo helisen depot 108+115+129 drevesa, nadaljevalno zdravljenje
kemofarmacija d.d. - suspenzija za injiciranje - drevesni cvetni prah